STAAR Surgical authorizes USD 50 million share repurchase program

• STAAR Surgical’s board, at a regularly scheduled meeting, authorized a share repurchase program of up to USD 50 million.
• Buybacks may be executed in the open market, via private transactions, structured agreements, block trades, or Rule 10b5-1 plans.
• Repurchase timing, price, and volume will be set at management’s discretion; the program can be modified, suspended, or ended.
• Program is expected to run for 12 months; funding planned from free cash flow and cash on hand.
• As of July 3, 2026, STAAR reported USD 181.5 million in cash and investments, no debt; about 50,100,000 shares outstanding as of Aug. 7, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. STAAR Surgical Company published the original content used to generate this news brief via Business Wire (Ref. ID: 202609241601BIZWIRE_USPR_____20260924_BW354417) on September 24, 2026, and is solely responsible for the information contained therein.